Novo Nordisk is collaborating with multiple telehealth organizations in an effort to increase patient access to authentic Wegovy.

Detailed price information for Lifemd Inc 8.875% Series A (LFMDP-Q) from The Globe and Mail including charting and trades.

Ooops... Something went wrong while loading this page.

These risks and uncertainties are described in the company's 10-K and 10-Q filings and within other filings that LifeMD may make with the SEC from time to time. Forward-looking statements made during ...

Q1 2025 Earnings Call Transcript May 6, 2025 Operator: Good afternoon. Thank you for joining us today to discuss LifeMD’s ...

Justin Schreiber, Chairman and CEO of LifeMD, said, "LifeMD had an outstanding first quarter that demonstrated the power of our platform, the need for our services and the accelerated growth ...

LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today reported financial results for the three months ended March 31, 2025.

Good afternoon. Thank you for joining us today to discuss LifeMD’s Results for the First Quarter ended March 31, 2025. Joining the call today are Justin Schreiber, Chairman and Chief Executive ...

LifeMD, a leader in virtual healthcare services with a market capitalization of $346.54 million, reported its Q1 2025 earnings, showcasing a strong financial performance that exceeded market ...

LifeMD, Inc. (LFMD) came out with quarterly earnings of $0.01 per share, beating the Zacks Consensus Estimate of a loss of $0.04 per share. This compares to loss of $0.19 per share a year ago.